Idarubicin containing regimen in multiple myeloma: preliminary results of a pilot study using a modified "TANDEM" transplant program.
about
Stem cell transplantation for multiple myeloma.A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study.
P2860
Idarubicin containing regimen in multiple myeloma: preliminary results of a pilot study using a modified "TANDEM" transplant program.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Idarubicin containing regimen ...... d "TANDEM" transplant program.
@en
Idarubicin containing regimen ...... d "TANDEM" transplant program.
@nl
type
label
Idarubicin containing regimen ...... d "TANDEM" transplant program.
@en
Idarubicin containing regimen ...... d "TANDEM" transplant program.
@nl
prefLabel
Idarubicin containing regimen ...... d "TANDEM" transplant program.
@en
Idarubicin containing regimen ...... d "TANDEM" transplant program.
@nl
P2093
P2860
P1433
P1476
Idarubicin containing regimen ...... ed "TANDEM" transplant program
@en
P2093
G C Pruneri
G Martinelli
P2860
P304
P356
10.1080/1042819021000029687
P577
2003-02-01T00:00:00Z